In Preparation
Robin Murphy, Stelios Kiosses, and Anna Marmodoro. In Preparation. “From Humean to Human: Targeting causal thinking as a basis for therapy’,”.Abstract

Patients have difficulty understanding from where their behaviors and thoughts emerge which contributes to their inability to respond to the therapeutic process. Causation is fundamental to thinking about change, but patients often come with impoverished conceptions of causation. Empirical cues to causality can be helpful but can also distort the representations of causal relations that underlie thinking. We hold that understanding a causal model in which the engines powering nature are relevant to the one's powering social interactions; and we propose that helping patients to understand causal powers and mechanisms relevant for their situation can enhance mental health. In contrast to the Humean understanding of agents-of-action which leaves the patients' understanding of their own conditions wanting, and the therapists' tools missing, causal powers are - we argue - a valuable tool for understanding causal relations. We discuss how i) causal thinking is a trans-diagnostic feature of psychological disorder; that ii) causal revaluation may be supported by an awareness of conditional dependencies and a causal powers model of thinking (e.g., Marmodoro 2009), and that iii) a systematic reappraisal of a patient's causal thinking may prove to be beneficial, because it provides insights to the about the origins of their thoughts and behaviors.

Stelios Kiosses. Forthcoming. THE POWER OF TALKING: Stories From The Therapy Room. Phoenix Publishing House. Publisher's VersionAbstract

Through the case studies in this book you will encounter various examples of psychological defences. You will come to understand the process of a client in psychotherapy who carries with them a brace of negative symptoms and a spectrum of psychological mechanisms by which he or she keeps a distance from others for fear of getting ‘hurt’. You will come to understand also how a therapist provides a compassionate and corrective experience to these clients by helping them to remove some of these defensive burdens. Through the case studies we will review the theoretical underpinnings and steps that are taken by therapists to reach through to the person beneath these resistances.

Stelios Kiosses. 4/1/2020. “Assessing The Psychological Impact of Acne.” The Consulting Room 3 (2), Pp. 42-43. Assessing Acne
Stelios Kiosses. 1/1/2020. “Seasonal Affective Disorder” 3 (1804), Pp. 44-46. Seasonal Affective Disorder
Stelios Kiosses. 6/29/2019. “Why We Should Trust the Synchronicity of Life.” Psychreg. Publisher's Version
Stelios Kiosses. 6/2/2019. “Attachment, Loss and the Space Between.” Psychreg. Publisher's Version
Stelios Kiosses. 5/29/2019. “When I Think of Death and Suicide It Makes Me Appreciate Life Even More.” Psychreg. Publisher's Version
Stelios Kiosses. 1/1/2019. “Assessing Patients For Body Dysmorphic Disorder (BDD) .” The Consulting Room 261 (1804), Pp. 42-45. Assessing BDD
5/26/2017. “Niccolini F, Diamantopoulos K, Kiosses S, Politis M. Be vigilant for dementia in Parkinson’s disease. Practitioner 2017;261(1804):11-15.” The Practitioner.Abstract
It is estimated that up to 80% of patients with Parkinson's disease will eventually develop cognitive impairment over the course of their illness. Even at the time of diagnosis, cognitive impairment has been reported in 20-25% of patients. Commonly affected cognitive domains are executive function, visuospatial ability and attention control. In addition, patients with Parkinson's disease dementia may present with deficits in language function and verbal memory. Psychosis may occur in approximately 40% of patients with Parkinson's disease, and is associated with an increased risk of developing cognitive impairment. Studies have shown that patients with Parkinson's disease with a history of visual hallucinations had an increased risk of developing dementia, four to eight years following diagnosis of the disease. Other clinical risk factors associated with cognitive decline in patients with Parkinson's disease include older age of onset, severe motor symptom burden and in particular akinetic-rigid subtype and olfactory dysfunction. Patients with Parkinson's disease who present with symptoms of cognitive decline, behavioural changes or psychotic symptoms should be referred for further investigation.